Sweden: IRRAS to list on Nasdaq Stockholm 

Swedish medtech company IRRAS is to list on Nasdaq Stockholm on 20 May. It currently trades on Nasdaq First North Premier Growth Market. “Following our recent capital raise in April, we are now in a strong financial position to continue the growth of IRRAS toward our goal of becoming a global leader in neurocritical care,”…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »